Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AstraZeneca Pharma India Limited
No Price
Closing Price XBOM 29.04.2026:
8.521,00 INR
29.04.2026 06:25
Current Prices from AstraZeneca Pharma India Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NSE
ASTRAZEN.NS
INR
29.04.2026 06:25
8.505,50 INR
55,50 INR
+0,66 %
MSE
ASTRAZEN.BO
INR
29.04.2026 05:47
8.521,00 INR
71,00 INR
+0,84 %
Share Float & Liquidity
Free Float18,41 %
Shares Float4,6 M
Shares Outstanding25 M
Company Profile for AstraZeneca Pharma India Limited Share
AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brand names; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brand names. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
